Tender Details

Country: Belarus
Summary: 25/ 03-8 Drug Interferon Beta-1A (Registered/ Unregistered Drugs)
BYT Ref No: 118153298
Deadline: 11 May 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: BYN 85069380
Notice Type: Tender
Document Ref. No.: AU20250423337405
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
25/ 03-8 drug Interferon Beta-1a (registered/ unregistered drugs)
Documents:

Tender Notice

25_03_81.doc

Prilogenie__1.xlsx

Prilogenie__3_nezar.xlsx

Dogovor_k_auktzionnym__dokumentam_MZ_RB_2025_dlya__rezidentov_proizvoditelei.doc

Dogovor__k_auktzionnym__dokumentam_MZ_RB_2025_dlya_rezidentov_posrednikov.doc

Kontrakt_k_auktzionnym__dokumentam_MZ_RB_2025_dlya_nerezidentov.doc

Dogovor__k_auktzionnym__dokumentam_MZ_RB_2025_dlya_rezidentov_posrednikov_NEZAREG.doc

Kontrakt_k_auktzionnym__dokumentam_MZ_RB_2025_dlya_nerezidentov_NEZAREG.doc

au_purchase_337405.xls

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

25/ 03-8 Drug Interferon Beta-1A (Registered/ Unregistered Drugs) - Belarus Tender

The RUP "BELFARMATION, a Government sector organization in Belarus, has announced a new tender for 25/ 03-8 Drug Interferon Beta-1A (Registered/ Unregistered Drugs). This tender is published on BelarusTenders under BYT Ref No: 118153298 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-11.

The estimated tender value is BYN 85069380, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.